Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

László Herszényi

László Herszényi

Past President of Hungarian Society of Gastroenterology Hungary

Robert Rahimi

Robert Rahimi

Baylor Scott and White Liver Consultants of Texas USA

Dimitar tonev

Dimitar tonev

Senior medical director, IQVIA UK

Magdy El-Salhy

Magdy El-Salhy

Professor of Gastroenterology and Hepatology at Bergen University Norway

William J. Rowe

William J. Rowe

Former Assistant Clinical Professor of Medicine, Medical University of Ohio at Toledo USA

Amr Amin

Amr Amin

UAE University UAE

Abdulrahman A. Aljumah

Abdulrahman A. Aljumah

King Abdulaziz Medical city Saudi Arabia

Lynnette Ferguson

Lynnette Ferguson

University of Auckland School of Medicine Newzealand

Gastroenterology 2023

Welcome Message

We would like to express my deepest sympathies on behalf of the organizing committee.

We gladly invite you to August 2023 main event, the 29th World Conference on Gastroenterology & Hepatology, which will be held on August 23-24, 2023 in Toronto, Canada. At this conference, you may anticipate hearing from leading professionals from all around the world and gaining insightful information. The Conference will provide a wide variety of content that is both ground-breaking and interesting. In addition to the usual abstract presentations and keynote addresses by distinguished invited speakers from across the world, we will also feature workshops, interactive sessions, and a variety of exhibitors.

About Conference


It gives us great pleasure to let you know that we will be holding a symposium on the "GASTRO-HEPATO: An Image From The Scope". In the domains of Gastroenterology and Hepatology, academic scientists, research scholars, academic researchers, students, and experts are all cordially invited. The GASTROENTEROLOGY 2023 conference this year offers a platform for experts to interact as well as a global venue for sharing and learning about research discoveries, original concepts, and best practice models.

Gastrointestinal disorders, gastrointestinal oncology, advanced nutrition and dietetics in gastroenterology, gallbladder cancer treatment, gastrointestinal pharmacology, kidney and pancreas transplant, liver and intestinal transplant, Neuro gastroenterology disorder, disease of liver cancer, and many other topics will be covered in sessions.

 

DETAILS OF THE CONFERENCE

CONFERENCE NAME

THEME

DATE

LOCATION

Gastroenterology Congress 2023

GASTRO-HEPATO: An Image From The Scope

August 23-24, 2023

Toronto, Canada

 

Why to Attend:

• Workshops for Graduates, Doctorates, and Postdoctoral analysisers Fellows in Post-Doctoral Research on              Career steerage

Accepted abstracts are going to be enclosed in databases like PubMed, MEDLINE, and others.

• A Digital Object positive identification, or DOI, are going to be appointed to every abstract.

• A Digital Object symbol, or DOI, was provided by Cross referee.

• For your name, Google's Speaker and Abstract pages are often informative.

• Your scientific credentials are going to be recognized all across the globe.

• Scientists and business leaders area unit expected to attend the meeting.

• Collaborative analysis opportunities.

• Panel discussions & interactive sessions.

 

Target Audience:                         

  •  Hepatology Professors
  •  Gastroenterology Professors
  •   Internal Medicine Physicians
  •  Healthcare Institutions
  •  Researchers and Scholars
  •  Pharmaceutical organizations
  •  Members of Gastroenterology and Hepatology Associations
  •  Gastroenterology and Hepatology Students
  •  Gastroenterology and Hepatology Scientists
  •  Gastroenterology and Hepatology Researchers
  •  Companies producing clinical gadgets

 

Features of Conference:

  1.  The ideal platform for international networking.
  2.  Possibilities for Collaborative Research.
  3.  Participants rights to share their work.
  4.  Make a sprinkle with a different thing as a gift.
  5.  Workshops, gatherings, and symposia that is well-structured.
  6.  Participate in a global session with live Q&A.
  7.  Keynote Speakers more than 7.
  8.  Plenary Speakers more than 50.
  9. There will be more than 20 exhibitors.
  10. 14 Cutting-Edge Educational Sessions.
  11.  Business to Business Meetings.

Session/Tracks

Session no.1:  Gastroenterology

The study of the oesophagus, stomach, small intestine, pancreas, gallbladder, bile ducts, and liver is known as gastroenterology. This covers prevalent and serious conditions such colon polyps, cancer, hepatitis, gastroesophageal reflux disease (heartburn), stomach ulcers, colitis, gallbladder disease, malnutrition, irritable bowel syndrome, and pancreatitis. It involves a detailed analysis of the normal function (physiology) of the gastrointestinal organs, including material flow through the stomach and digestive system, nutrient absorption and retention in the body, waste disposal from the body, and the liver's role as a digestive organ.

• Barrett's Esophagus.

• Celiac Disease.

• Colorectal Cancer.

• Gallbladder and Biliary Disease.

 

Session no. 2:  Advance Nutrition and Dietetics in Gastroenterology

In-depth and current coverage of the connection between nutrition, food, and the gastrointestinal tract can be found in Advanced Nutrition and Dietetics in Gastroenterology. In addition to examining the impacts of diet and available treatments, it looks into how dietary factors may contribute to the onset of a variety of gastrointestinal disorders. Nowadays, the word "probiotics" is used to describe consuming microorganisms that are beneficial to both humans and animals. Numerous advantages of probiotics include easing constipation, boosting immunological function, and lowering gastrointestinal stress. You can use dietary supplements like dietary enzymes and unicellular proteins.
gastrointestinal GI is mainly responsible for the following:

• Acquiring and digesting food

• Absorbing nutrients and water  

 

Session no. 3:  Gastrointestinal Disorders

Since these records were originally used in medical thousands of years ago, In contrast to earlier methods, which were often based on tradition or authority, modern medical guidelines are based on an examination of current facts under the paradigm of evidence-based medicine. They often consist of condensed consensus declarations on fundamental concepts of healthcare. There are articles on gastrointestinal issues as well as clinical practise guidelines. A range of disease-causing organisms or germs that can be acquired by the consumption of tainted food or beverages, contact with tainted recreational water, contact with diseased animals or their habitats, or contact with infected people are the cause of human gastrointestinal illness.

• Hemorrhoids

• Internal hemorrhoids

• External hemorrhoids

 

Session no.4:  Liver & Intestine Transplant

Intestine transplant recipients have a one-year survival rate of more than 85%, which is similar to that of liver transplant recipients. A study that appeared in Nature found that keeping livers warm reduced damage by 50% compared to putting them on ice. If damage is decreased, the number of organs that are suitable for transplant will significantly increase. The liver is kept in a physiological state by the new technology perfusion system, which also keeps it warm and supplies it with blood and nutrients. This can aid in the liver's recovery from whatever harm it may have sustained during the removal of the donor.

•     Solated intestinal graft

•    Combined intestinal-liver graft

•    Multivisceral graft

 

Session no. 5: Neuro gastroenterology Disorder

The field of neuro-gastroenterology examines the brain. Neurogastroenterology and motility (NGM) disorders are common and entail high medical expenses. There is still concern regarding unmet training requirements and a lack of expertise treating patients with NGM problems despite the fact that paediatric gastroenterology fellows are intended to receive comprehensive training in the diagnosis and management of NGM illnesses. The purpose of our study was to better understand the NGM training experiences of paediatric gastroenterology fellows in North America and to determine how those experiences affected their interest in a career involving GM issues in neurogastroenterology.

• Enteric glial biology

• Intercellular signalling and roles in gastrointestinal disease

• Disorders of the enteric nervous system

 

Session no. 6: Disease of Liver Cancer

For instance, persistent hepatitis infections are a well-known source of liver cancer. The aetiology of liver cancer is unclear, though it can develop in persons without an underlying illness. Infections and alcohol usage are just two examples of the various variables that can harm the liver and result in liver disease. Liver disease can also be acquired (hereditary). Additionally, liver damage is linked to obesity. Over time, liver damage may result in cirrhosis, a condition that can endanger one's life.

• Chronic (long-term) infection

• Chronic (long-term) infection with hepatitis B virus

• Chronic (long-term) infection with hepatitis C virus

 

Session no. 7: Hepatitis Infections

Hepatitis is a term for a liver infection that is inflammatory. Hepatitis can have different origins aside than viral infections, which are frequently its source. These include autoimmune hepatitis and hepatitis brought on by alcohol, drugs, poisons, and other substances. An inflammation of the liver is known as hepatitis. This syndrome can be brought on by alcohol use, a number of medical disorders, and several drugs. However, the most typical cause of hepatitis is viral infections. The five main types of hepatitis viruses are

• Hepatitis A

• Hepatitis B

• Hepatitis C

• Hepatitis D

• Hepatitis E

 

Session no. 8: Hepato-pancreato-biliary disease

Darker urine and lighter stool are also frequent signs or symptoms of various disorders. Hepatobiliary disease is any anomaly of the hepatobiliary system that prevents it from operating normally. From a little infection or scarring to more serious conditions like cancer, it can fluctuate in severity. The hepatobiliary system's organs are the liver, gallbladder, and bile ducts. While some are inherited or congenital, the majority are brought on by chronic damage to the tissues of the organs in question.

 

Session no. 9 : Gastrointestinal and Minimally Invasive Surgery

A bone or anatomically related components like cartilage, ligaments, or tendons are the focus of an orthopaedic surgical intervention. As these tissues are often located far inside the human body, extensive surgical exposure is required to gain access to the intervention's objectives.

There are three key reasons for the demand for less invasiveness:

•   Implants, such as screws, nails, or endoprotheses, are used in numerous orthopaedic                         developments.

•   The surgeon must be able to see the operation field.

•   Surgical devices must have an effect on the bone.

 

Session no. 10: Irritable Bowel Syndrome

Irritable Bowel Syndrome is a functional problem, not a disease. In other words, the Bowel doesn't function as it should. The market for treating irritable bowel syndrome was valued USD 1.5 billion in 2019, and a CAGR of 10.1% was anticipated for the following year. Irritable bowel syndrome is among the conditions that affect the large intestine most frequently. This disorder can cause cramps, stomach pain, bloating, diarrhoea, gas, and constipation. Some people can manage their symptoms with the help of diet, lifestyle changes, and stress management. More severe symptoms can be treated with medication, and counselling doesn't affect your intestinal tissue or increase your risk of developing colon cancer.

•  Cramping

•  Abdominal pain

•  Bloating, gas

•  Diarrhea

 

Session no. 11:  Ulcerative Colitis and Crohn’s Disease

While ulcerative colitis is only seen in the colon, Crohn's disease can affect any part of the body from the mouth to the anus. In Crohn's disease, there are healthy portions of the intestine interspersed between inflammatory regions. The colon is chronically inflamed with ulcerative colitis, on the other hand. Both of them suffer from an inflammatory bowel condition (IBD). Seminerio, an assistant professor and the center's director for inflammatory bowel disease at the University of South Florida, said. "When talking about ulcerative colitis, especially when you're in the mild to severe disease states, it's crucial to categorize whatever ulcerative colitis disease state you're dealing with using severity index scores and endoscopic scores.

 

Session no.12: Hepatic Hemangioma

The most common benign (noncancerous) tumours in or on the liver are hepatic hemangioma (HH) tumours. A network of blood vessels, endothelial cells that line the blood vessels, and the hepatic artery, which provides the bulk of the mass's fuel, make up the tumour. Hepatocellular cavernous or capillary hemangioma is another name for this tumour.

.  The following are some of the indications and symptoms of a liver hemangioma:

•  In the upper right abdomen, there is a pain.

•  Having a full stomach after having a tiny amount of food

•  Nausea

 

Session no.13: Gastrointestinal Infection and Viral Gastroenteritis

Watery diarrhoea, stomach spasms, nausea, vomiting, and occasionally fever are all signs and symptoms of viral gastroenteritis, an intestinal infection.

Contact with an infected person or ingestion of tainted food or water is the most typical way to get viral gastroenteritis, often known as gastroenteritis. If you are otherwise healthy, you might make a full recovery. Viral gastroenteritis, however, can be fatal in young children, the elderly, and those with compromised immune systems.

•  Constipation. ...

•  Irritable bowel syndrome (IBS) ...

•  Hemorrhoids. ...

•  Internal hemorrhoids

 

Session no. 14: Gall Bladder Cancer Treatment

The procedures are used to treat gallbladder cancer that is localised and that has spread locally. During surgery, the gallbladder and some of the surrounding tissue are removed. It is possible to remove a piece of the liver as well as nearby lymph nodes. Following surgery, radiation therapy may be combined with or without chemotherapy. One therapeutic option is radiation therapy, either with or without chemotherapy. radio sensitizers are used in radiation therapy in a clinical trial.

 

Session no. 15: Gastrointestinal Pharmacology

Treatment for gastrointestinal diseases is necessary, and there are two types of pharmaceutical therapies: prescription drugs and over-the-counter drugs (OTC Drugs). In order to treat problems with the gastrointestinal tract, gastrointestinal tract dividers, and gastrointestinal motility, the medications are administered. Gastrointestinal pharmacology is the study of the properties and functions of drugs that affect the digestive system.It is in charge of:

•   Providing essential nutrients to the body;

•   Maintaining optimal blood levels of all vital nutrients to allow for normal activities;

•   Toxic waste inside the body is avoided by eliminating wastes obtained from the diet                         and some products of the body's metabolism.

 

Session no. 16: Gastrointestinal Oncology

Cancers of the digestive system and other organs that exhibit symptoms of internal death, extreme pain, distension, dysphagia, or prolonged constipation or the inability to handle difficult stool movements The phrase "gastrointestinal oncology," which covers a wide range of gastrointestinal tract and gastrointestinal cancers, is very broad. called stomach cancer as well. This suggests that the most prevalent type of cancer is gastrointestinal cancer in its malignant condition.Treatment of GI cancer depends on the type of cancer, the stage of the cancer, and how the cancer spreads. Diseases that can be treated with gastrointestinal oncology include:

• Esophageal Cancer

• Anal Cancer

• Stomach (Gastric) Cancer

Session no.17:  Kidney and Pancreas Transplant

A kidney-pancreas transplant includes inserting a kidney and a pancreas into a patient who has type 1 diabetes-related renal failure. In many cases, the deceased donor of both transplanted organs may be the same. Additionally, dead donor kidney-pancreas transplants have very high success rates. The best outcomes are frequently attained when the kidney and pancreas both come from a deceased donor. This is as a result of the significantly reduced likelihood of rejection. One kidney and a portion of the pancreas have, however, already been donated in a number of successful living donor transplants.

• Overcoming antibody barriers.

• Reducing disease recurrence.

• Improving long-term success

 

Session no. 18: Gastrointestinal Diseases during Pregnancy

Even if you didn't have any before becoming pregnant, digestive issues are common. The causes can vary because they are different. Changes in hormones, GI motility difficulties, obesity, specific drugs, a poor diet, stress, and other variables are some of the most frequent reasons or risk factors for digestive issues during pregnancy. Chronic gastrointestinal conditions necessitate treatment throughout pregnancy, raising the intriguing question of whether the benefits to the mother could endanger the unborn child. Additionally, some illnesses, including acute fatty liver of pregnancy, only manifest themselves during pregnancy, needing urgent measures like preterm delivery.

• Pregnancy hormones

• Hyperemesis gravidarum

• Gastroesophageal reflux disease

 

Sesssion no. 19: Advanced Research in Gastroenterology and Hepatology

A peer-reviewed, open-access, worldwide medical journal that publishes every two weeks and covers all facets of gastroenterology and hepatology is called Advanced Research in Gastroenterology and Hepatology. Gastroenterology is a branch of medicine that focuses on issues relating to the digestive system. Proctology is a sub-specialty of general surgery that focuses on the anus, rectum, and colon, while Advanced Research in Gastroenterology and Hepatology, or hepatobiliary medicine, is a sub-specialty of gastroenterology that investigates the liver, pancreas, and biliary tree.

 

Session no. 20: Advanced Hepatology

The demand for hepatologists who are qualified to treat patients with chronic liver disease and liver transplantation has significantly increased as the area of general hepatology continues to develop and expand and as the number of liver transplant cases rises. The study, prognosis, analysis, and treatment of infectious disorders that affect the pancreas, gallbladder, liver, and bile ducts are all included within the medical specialty of hepatology. Hepatitis C virus infection will be eliminated in the future of hepatology, and new difficulties have emerged. As a result, in-depth training is absolutely important to get extra information and skills in this specific gastroenterology subspecialty. The American Board of Internal Medicine started giving certification tests for transplanted hepatology in November 2006. It is now recognized as a discipline in its own right.

• Liver : Non-Neoplastic Diseases

•  Abnormal liver tests

• Autoimmune liver disease

 

Session no. 21:  Hepatitis Vaccination

You need two doses of the hepatitis A vaccine, given as shots six months apart, for complete protection. The vaccine destroys the virus it carried (inactive). Three to four doses are necessary for long-lasting immunity, depending on the type of immunisation given. They are given to you as shots. The series should be finished by six months of age, with the first dosage administered at birth. At one month and six months, respectively, a second and third dose are often administered.

•  Hepatitis A

•  Hepatitis B

•  Hepatitis C

 

Session no. 22: Peptic Ulcer Disease

Any area of the GI system that comes into contact with gastric secretion, such as the lower oesophagus, stomach, and duodenum, is susceptible to developing ulcers. Only in an acidic environment do ulcers develop. An ulcer can develop without having a lot of stomach acid. A person with a gastric ulcer has normal to less than normal gastric acidity when compared to a person with a duodenal ulcer. In the past, people used to think that certain foods or stress may cause ulcers. However, no evidence supporting their opinions has been provided. Ulcers are caused by two main factors, according to research

•  Bacteria Helicobacter pylori (H. pylori).

•  NSAIDs (non steroidal anti-inflammatory drugs)

 

Session no. 23 : metabolic liver diseases

The majority are brought on by a metabolic pathway being thrown off due to an enzyme or transport protein deficit. This group of ailments differs from what is known as a metabolic disorder. Adults who have metabolic syndrome—more specifically, metabolic syndrome—are affected by this disorder. One of these is visceral obesity. These illnesses are split into two categories.

•  Another is alpha-1-antitrypsin deficiency (A1ATD).

• Cystic fibrosis is a disease that affects the lungs (CF)

 

Session no. 24 :  Obesity and Bariatric Surgery

In addition to a lack of physical activity or a regular schedule, obesity is brought on by an imbalance between calorie intake and utilisation. The purpose of this procedure is to decrease stomach capacity, which restricts the amount of food the stomach can hold at any given time and promotes early satiety. It helps to stop food from being digested, which lowers the amount of calories that are released into the body. People who are obese and desire to lose weight often undergo bariatric surgery, sometimes referred to as metabolic surgery.

 

Session no. 25: Gastrointestinal Bleeding and Pathology

As is common knowledge, GI (Gastrointestinal) bleeding is a symptom, not a disease in and of itself. GI (Gastrointestinal) bleeding may be caused by haemorrhoids, peptic ulcers, rips or inflammation in the oesophagus, diverticulosis and diverticulitis, ulcerative colitis and Crohn's disease, colonic polyps, or cancer of the colon, stomach, or oesophagus. The investigation and management of bleeding in gastroenterology continue to be challenging. A typical study includes excluding systemic or haematological disorders, asking about drug usage, looking for paracites, barium studies, and a thorough endoscopic examination. If the test results are negative, the patient most likely has one or more small gastrointestinal vascular abnormalities.

•  Overt (acute)

•  Occult (chronic)

•  Obscure

Market Analysis

The market for gastrointestinal treatments is anticipated to grow to a value of USD 13.8 billion by 2020, with a CAGR of 6.5 percent between 2015 and 2020. This increase in market size is attributed to a number of factors, including rising biologics consumption, tentative approval of late-stage molecules, the development of novel therapies using cutting-edge technologies, and an increase in the number of people seeking treatment due to better diagnostic tools.

The Competitive Scenario is a perspective analysis of the various company expansion tactics used by the suppliers. The news in this section keeps readers informed at various points in the business cycle and involves participants in the economic discussion. The competitive scenario represents the categories of merger and acquisition, agreement, collaboration, and partnership, new product launch and enhancement, investment and funding, and award, recognition, and expansion. The vendor can improve their product and service by using the information acquired to pinpoint market insufficiencies as well as strengths and weaknesses of competitors.

The biggest issue is that there aren't enough qualified doctors and endoscopists in the market. To reduce the transmission of infections in endoscopy facilities, endoscopic procedures must be carried out by qualified professionals. The amount of endoscopic treatments carried out annually is anticipated to suffer due to the global shortage of skilled endoscopy doctors and nurses. A few market participants, including Olympus, have created training facilities to address this problem. In Asia alone, the organisation has 22 endoscopic training facilities. Such initiatives will increase the number of certified endoscopy professionals while also improving awareness of the most recent technical developments in the field. If we discuss the potential in the gastrointestinal market, The healthcare industry is expanding in emerging economies, like Russia. The BRICS nations—Brazil, Russia, India, and China—have some of the quickest economies in the world.       

 

 

Worldwide Associations/Societies of Gastroenterology:

Gastroenterological Society of Singapore

Spanish Society- Endoscopy

United European Gastroenterology (UEG)

European Board of Gastroenterology and Hepatology (EBGH)

The Hong Kong Society of Gastroenterology

United European Gastroenterology

British Society of Gastroenterology

Gastroenterological Society of Australia

European Society of Gastrointestinal and Abdominal Radiology.

The International Liver Cancer Association

The Japanese Society of Gastroenterology

The Italian Society of Gastroenterology

To Collaborate Scientific Professionals around the World

Conference Date August 23-24, 2023

Speaker Opportunity

Supported By

Research and Reports in Gastroenterology Journal of Health and Medical Research Journal of Hepatology and Gastrointestinal disorders

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by